Programmed Death Ligand 2 in Cancer-Induced Immune Suppression.
| Autor: | Rozali, Esdy N.1, Hato, Stanleyson V.2, Robinson, BruceW.1,3, Lake, Richard A.1,3, Joost Lesterhuis, W.1,4 w.lesterhuis@onco.umcn.nl |
|---|---|
| Zdroj: | Clinical & Developmental Immunology. 2012, p1-8. 8p. 1 Diagram. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|